Payer strategy for emerging biotechs.
Access Navigate helps emerging biotech teams build payer strategy before key decision milestones.
We support preclinical, Phase 1, Phase 2, Phase 3, and pre-launch teams preparing for clinical development, investor meetings, BD partnering, licensing, acquisition, diligence, and launch.
Pricing, reimbursement, and access shape value long before approval. They affect indication choice, trial design, comparators, endpoints, evidence planning, investor valuation, BD strategy, and launch sequencing.
Access Navigate is a specialized advisory for biotech CEOs, CBOs, BD teams, clinical leaders, investors, and scientific founders who need senior payer strategy input before important decisions.
Three Payer Questions Shape Asset Value
Understanding these questions early informs critical decisions that protect and enhance your asset's potential.
Pricing Potential
Reimbursement & Access
Payer Strategy Roadmap
What is the realistic price, and what evidence is needed to support it?
How would payers cover, restrict, or value your product?
What is the payer value proposition, evidence plan, and access roadmap?








Our Clients
Strategic Guidance for Biotech Leaders
CEOs & CBOs
Define market access strategy, build pricing assumptions, and prepare for BD partnering and commercial diligence.
Clinical Development Teams
Align trial design, endpoints, and evidence planning with future payer requirements for optimal asset value.
Investors
Validate commercial assumptions, assess payer risk, and understand market access implications for asset valuation and financing rounds.
Scientific Founders
Translate scientific innovation into a compelling payer value proposition that secures future market access and reimbursement.
Payer Readiness Diagnostic
Payer Strategy Hypothesis
Early read on price potential, reimbursement risk, payer evidence gaps, and value implications.
Senior advisory engagement to define payer strategy, build pricing assumptions, and outline an access roadmap.
Flexible Market Access Retainer
Ongoing senior payer strategy support to navigate evolving market dynamics and critical milestones.
